Organization
Department of Oncology, University Hospital of North Norway, Tromso, Norway
2 abstracts
Abstract
High dose chemotherapy in male patients with germ cell cancer: A population-based study by the SWENOTECA group.Org: Department of Immunology, Genetics & Pathology, Uppsala University, Uppsala, Sweden, Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden, Department of Oncology, Oslo University Hospital, Oslo, Norway, The Cancer Clinic, St. Olavs University Hospital, Trondheim, Norway, Department of Oncology, Skåne University Hospital, Lund, Sweden,
Abstract
Final survival data from a randomized phase II trial comparing high-dose with standard-dose twice-daily (BID) thoracic radiotherapy (TRT) in limited stage small-cell lung cancer (LS SCLC).Org: Norwegian University of Science and Technology (NTNU), Department of Thoracic Medicine, Haukeland University Hospital, Department of Oncology, Oslo University Hospital, Oslo, Oslo, Norway, Stavanger University Hospital, Department of Oncology, Odense University Hospital,